论文部分内容阅读
Whole genome and exome sequencing (WGS and WES) of circulating cell-free DNA (cfDNA) from plasma has recently been used in landmark proof-of-concept studies as a technique to assay circulating tumor DNA (ctDNA) and circulating fetal DNA.Generally,only a few nanograms of fragmented (approximately 170 bp) cfDNA are recovered per milliliter of plasma.